Skip to content

Opening book details…

Can I read The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer on EtoBox?

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer by Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phillip J. Stella; Richard L. Deming; James R. Jett; Yolanda I. Garces; Katie L. Allen; Alex A. Adjei; for the North Central Cancer Treatment Group is a Medicine article available to read on EtoBox.

What is The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer about?

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell lung cancer (NSCLC). ## METHODS. The North Central Cancer Treatment Group performed 2 recent Phase III trials for stage III NSCLC. The first trial, NCCTG 90‐24‐51, included 3 arms: once‐daily RT (QDRT) alone, twice‐daily RT (BIDRT) alone, and concurrent chemotherapy plus BIDRT. The second trial, NCCTG 94‐24‐52, included 2 arms and compared concurrent chemotherapy with either QDRT or BIDRT. The chemotherapy arms of both trials included etoposide and cisplatin administered concurrently with RT. Only the patients aged ≥65 years (elderly) who participated in those trials were included in this analysis. ## RESULTS. Of the 166 elderly patients who were included in this analysis, 37 patients received RT alone, and 129 patients received concurrent chemotherapy plus RT. The median and 5‐year survival rates were 10.5 months and 5.4% for the RT alone group compared with 13.7 months and 14.7% for the R

Who reads The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phillip J. Stella; Richard L. Deming; James R. Jett; Yolanda I. Garces; Katie L. Allen; Alex A. Adjei; for the North Central Cancer Treatment Group
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
2007
Language
EN
Field
Medicine (Health Sciences)

More by Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phillip J. Stella; Richard L. Deming; James R. Jett; Yolanda I. Garces; Katie L. Allen; Alex A. Adjei; for the North Central Cancer Treatment Group

Browse all works by Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phillip J. Stella; Richard L. Deming; James R. Jett; Yolanda I. Garces; Katie L. Allen; Alex A. Adjei; for the North Central Cancer Treatment Group